Report overview
A progestogen, also referred to as a progestagen, gestagen, or gestogen, is a type of medication which produces effects similar to those of the natural female sex hormone progesterone in the body. A progestin is a synthetic progestogen. Progestogens are used most commonly in hormonal birth control and menopausal hormone therapy.
They can also be used in the treatment of gynecological conditions, to support fertility and pregnancy, to lower sex hormone levels for various purposes, and for other indications.
This report contains market size and forecasts of Gynecological Progestin Drugs in global, including the following market information:
Global Gynecological Progestin Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gynecological Progestin Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Gynecological Progestin Drugs companies in 2021 (%)
The global Gynecological Progestin Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Progesterone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gynecological Progestin Drugs include Merck, Teva Generics, Besins Healthcare, Virtus Pharmaceuticals, LLC, BionPharma, Aquatic Remedies, Zhejiang Xianju Pharmaceutical, Zhejiang Aisheng Pharmaceutical and Zhejiang Medicine, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gynecological Progestin Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gynecological Progestin Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gynecological Progestin Drugs Market Segment Percentages, by Type, 2021 (%)
Progesterone
Dydrogesterone
Others
Global Gynecological Progestin Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gynecological Progestin Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Gynecological Progestin Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gynecological Progestin Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gynecological Progestin Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gynecological Progestin Drugs revenues share in global market, 2021 (%)
Key companies Gynecological Progestin Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Gynecological Progestin Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Teva Generics
Besins Healthcare
Virtus Pharmaceuticals, LLC
BionPharma
Aquatic Remedies
Zhejiang Xianju Pharmaceutical
Zhejiang Aisheng Pharmaceutical
Zhejiang Medicine
Hubei Dongxin Pharmaceutical
Tianjin Jinyao Pharmaceutical
Guangzhou Baiyunshan Mingxing Pharmaceutical
